Latest on Pharmaceutical Industry


Roche cancer immunotherapy Tecentriq wins EU approval

Roche immunotherapy Tecentriq has won European Union approval for treating advanced lung and bladder cancer, the Swiss drugmaker said. The European Commission approved Tecentriq, also known as atezolizumab, as a monot..Read More...

FDA declines to approve J&J arthritis drug sirukumab

The U.S. Food and Drug Administration has declined to approve Johnson & Johnson’s rheumatoid arthritis drug sirukumab, saying additional clinical data is needed to further evaluate its safety, the company said on Frida..Read More...



Annual International Conference on Pharmacology and Pharmaceutical Sciences (PHARMA) 2017

Hotel Fort Canning,
Global Science And Technology Forum


15th Annual Global Forum

Hyatt Regency McCormick Place ,

Press Releases

Exelixis Provides Update on Collaborator Daiichi Sankyo’s Phase 3 Clinical Progress with Esaxerenone (CS-3150), Including Positive Top-Line Results and Additional Pivotal Study

Exelixis Inc announced that its partner Daiichi Sankyo Company Limited has reported positive topline results from a phase 3 pivotal trial of esaxerenone INN code name CS3150 a product of the companies prior research coll.. Read More...

Avara Pharmaceutical Services acquires Consumer Healthcare facility from GSK in Aiken, South Carolina

Avara Pharmaceutical Services has signed an agreement with GSK to acquire a GSK consumer healthcare manufacturing facility in Aiken South Carolina This acquisition is an important component of our strategic plan and expa.. Read More...

Suppliers of the Month

Product Launch



Latest Reports


Latest Projects


Expert Talk

Bayer Pharmaceuticals

Bayer Pharmaceuticals Christoph Huwe PhD CAAM is a Strategic Alliance Manager Therapeutics at Bayer AG Pharmaceuticals with a focus on the BayerEvotec Endometriosis BayerEvotec Kidney Diseases BayerOncoMed Oncology strategic alliances and the Tuberculosis Drug Accelerator consortium He is also a member of Bayers Alliance. Read More...
Christoph Huwe
Strategic Alliance Manager Therapeutics